----

----

| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|-----------------------------------------------------------------------------------------|

| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|------------------------------------------------------------------------------------------|

| Delaware(State or other jurisdiction ofincorporation or organization)                    | 27-2506234(I.R.S. EmployerIdentification No.)  |
|-----------------------------------------------------------------------------------------------|-----------------------------------------------------|
| 1 International Boulevard - Suite 400Mahwah, NJ (Address of principal executive offices) |  07495-0027(Zip Code)                          |

|   | Large accelerated filer o    | Accelerated filer o         |
|--------|------------------------------|-----------------------------|
|   |                         |                        |
|   | Non-accelerated filer o | Smaller reporting company x |

----

----

| PART I – FINANCIAL INFORMATION |                                                                                        |   | 1      |   |
|--------------------------------------|---------------------------------------------------------------------------------------------|--------|--------|--------|
|                                 |                                                                                        |   |   |   |   |
| ITEM 1                               | Financial Statements                                                                        |   |   | 2      |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 2                               | Management’s Discussion and Analysis of Financial Condition and Results of Operations |   |   | 15     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 3                               | Quantitative and Qualitative Disclosures About Market Risk                                  |   |   | 17     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 4                               | Controls and Procedures                                                                     |   |   | 17     |   |
|                                 |                                                                                        |   |   |   |   |
| PART II – OTHER INFORMATION    |                                                                                        |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 1                               | Legal Proceedings                                                                           |   |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 1A                              | Risk Factors                                                                                |   |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 2                               | Unregistered Sales of Equity Securities and Use of Proceeds                                 |   |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 3                               | Defaults Upon Senior Securities                                                             |   |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 4                               | (Removed and Reserved)                                                                      |   |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 5                               | Other Information                                                                           |   |   | 19     |   |
|                                 |                                                                                        |   |   |   |   |
| ITEM 6                               | Exhibits                                                                                    |   |   | 21     |   |

----

----

| ITEM 1 | Financial Statements |
|--------|----------------------|

|                                                                                                                                                                          |   | March 31,   |      |   | December 31, |   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------|-----------|--------|--------------|--------|
|                                                                                                                                                                          |   | 2011        |      |   | 2010         |   |
|                                                                                                                                                                          |   | (Unaudited) |      |   | (Note 2)     |   |
| Assets                                                                                                                                                                        |   |
|                                                                                                                                                                          |   |        |      |   |         |   |
| Current assets:                                                                                                                                                               |   |        |      |   |         |   |
|                                                                                                                                                                          |   |        |      |   |         |   |
| Cash                                                                                                                                                                          |   | $           | 194,890   |   |         | $      | 19,997 |   |
| Accounts receivable                                                                                                                                                           |   |        | 109,160   |   |         |   | - |   |
| Prepaid expenses and other current assets                                                                                                                                     |   |        | 11,693    |   |         |   | 16,936 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Total current assets                                                                                                                                                          |   |        | 315,743   |   |         |   | 36,933 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Fixed assets, net                                                                                                                                                             |   |        | 80,737    |   |         |   | - |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Intangible asset                                                                                                                                                              |   |        | 3,711,223 |   |         |   | 2,950,000 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Total assets                                                                                                                                                                  |   | $           | 4,107,703 |   |         | $      | 2,986,933 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Liabilities and Stockholders' Equity (Deficiency)                                                                                                                             |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Current liabilities:                                                                                                                                                          |   |        |      |   |         |   |   |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Accounts payable & accrued expenses                                                                                                                                       |   | $           | 268,629   |   |         | $      | 48,375 |   |
| Notes payable                                                                                                                                                                 |   |        | 1,429,798 |   |         |   | 1,468,465 |   |
| Notes payable - Due to related party                                                                                                                                          |   |        | 35,000    |   |         |   | 35,000 |   |
| Stock subscription payable                                                                                                                                                    |   |        | 750,000   |   |         |   | 750,000 |   |
| Stock subscription payable - Due to related party                                                                                                                             |   |        | 100,000   |   |         |   | 100,000 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Total current liabilities                                                                                                                                                     |   |        | 2,583,427 |   |         |   | 2,401,840 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Notes payable                                                                                                                                                                 |   |        | 333,333   |   |         |   | 666,667 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Total liabilities                                                                                                                                                             |   |        | 2,916,760 |   |         |   | 3,068,507 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Commitments and contingencies                                                                                                                                                 |   |        |      |   |         |   |   |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Stockholders' equity (deficiency):                                                                                                                                            |   |        |      |   |         |   |   |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Preferred stock, $0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding                                                                            |   |        | -         |   |         |   | - |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Common stock, $0.0001 par value, 250,000,000 shares authorized, 16,325,623 and 15,125,000 and issued and outstanding as of March 31, 2011 and December 31, 2010, respectively |   |        | 1,631     |   |         |   | 1,512 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Additional paid-in capital                                                                                                                                                    |   |        | 2,052,436 |   |         |   | 228,608 |   |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Accumulated deficit                                                                                                                                                           |   |        | (863,124  | )      |         |   | (311,694 | ) |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Total stockholders' equity (deficiency)                                                                                                                                       |   |        | 1,190,943 |   |         |   | (81,574 | ) |
|                                                                                                                                                                          |   |        |      |   |         |   |   |   |
| Total liabilities and stockholders' equity (deficiency)                                                                                                                       |   | $           | 4,107,703 |   |         | $      | 2,986,933 |   |

----

| Heartland Bridge Capital, Inc. and Subsidiaries |
|-------------------------------------------------|
| (Formerly I-Web Media, Inc.)                    |
| Condensed Consolidated Statement of Operations  |
| For the three months ended March 31, 2011       |
| (Unaudited)                                     |

| Revenues                                                       |   | $      | 2,965      |   |
|----------------------------------------------------------------|--------|--------|------------|--------|
|                                                           |   |   |       |   |
| Cost of revenues                                               |   |   | 11,882     |   |
|                                                           |   |   |       |   |
| Gross profit (loss)                                            |   |   | (8,917     | )      |
|                                                           |   |   |       |   |
| Operating expenses:                                            |   |   |       |   |
|                                                           |   |   |       |   |
| Research and development                                       |   |   | 64,730     |   |
| General and administrative                                     |   |   | 424,495    |   |
|                                                           |   |   |       |   |
| Total operating expenses                                       |   |   | 489,225    |   |
|                                                           |   |   |       |   |
| Operating loss                                                 |   |   | (498,142   | )      |
|                                                           |   |   |       |   |
| Other income (expense):                                        |   |   |       |   |
|                                                           |   |   |       |   |
| Interest expense                                               |   |   | (53,288    | )      |
|                                                           |   |   |       |   |
| Other income (expense)                                         |   |   | (53,288    | )      |
|                                                           |   |   |       |   |
| Net loss                                                       |   | $      | (551,430   | )      |
|                                                           |   |   |       |   |
|                                                           |   |   |       |   |
| Net loss per common share - Basic and diluted                  |   | $      | (0.04      | )      |
|                                                           |   |   |       |   |
| Weighted average common shares outstanding - Basic and diluted |   |   | 15,309,158 |   |

----

|                                                                                                                                                    |   | Preferred Stock  |   |   |         |   |   | Additional |   |   |        |   |   | Total   |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------|--------|--------|--------------|--------|--------|------------|--------|--------|-------------|--------|--------|---------|--------|
|                                                                                                                                                    |   | Series A & B |   |   | Common Stock |   |   | Paid-In    |   |   | Accumulated |   |   | Equity  |   |
|                                                                                                                                                    |   | Shares           |   |   | Amount       |   |   | Shares     |   |   | Amount      |   |   | Capital |   |   | Deficit |   |   | (Deficiency) |   |
| Balance, December 31, 2010                                                                                                                              |   |             | -      |   |         | $      | -      |       |   |   | 15,125,000  |   |   | $       | 1,512  |   |   | $ | 228,608 |   |   | $ | (311,694 | ) |   | $ | (81,574 | ) |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Issuance of common stock for cash at $1.75 per share  (Note 6)                                                                                |   |             | -      |   |         |   | -      |       |   |   | 41,430      |   |   |    | 4      |   |   |   | 72,499 |   |   |   | - |   |   |   | 72,503 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Issuance of common stock for cash at $1.00 per share in connection with exercise of warrants (Note 7)                                                   |   |             | -      |   |         |   | -      |       |   |   | 92,799      |   |   |    | 9      |   |   |   | 92,790 |   |   |   | - |   |   |   | 92,799 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Issuance of common stock valued at $1.75 per share in connection with the acquisition of the iSafe companies  (Note 8)                        |   |             | -      |   |         |   | -      |       |   |   | 500,000     |   |   |    | 50     |   |   |   | 874,950 |   |   |   | - |   |   |   | 875,000 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Issuance of warrants in connection with the acquisition of the iSafe companies  (Note 8)                                                      |   |             | -      |   |         |   | -      |       |   |   | -           |   |   |    | -      |   |   |   | 95,400 |   |   |   | - |   |   |   | 95,400 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Issuance of common stock at $1.00 per share in connection with the settlement of accrued interest and principal  (Notes 5 and 6(b)) |   |             | -      |   |         |   | -      |       |   |   | 521,894     |   |   |    | 52     |   |   |   | 521,842 |   |   |   | - |   |   |   | 521,894 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Amortization of share-based compensation                                                                                                                |   |             | -      |   |         |   | -      |       |   |   | -           |   |   |    | -      |   |   |   | 123,521 |   |   |   | - |   |   |   | 123,521 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Shares issued for services                                                                                                                              |   |             | -      |   |         |   | -      |       |   |   | 44,500      |   |   |    | 4      |   |   |   | 35,596 |   |   |   | - |   |   |   | 35,600 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Warrants issued for services                                                                                                                            |   |             | -      |   |         |   | -      |       |   |   | -           |   |   |    | -      |   |   |   | 7,230 |   |   |   | - |   |   |   | 7,230 |   |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                                                                                                                                |   |             | -      |   |         |   | -      |       |   |   | -           |   |   |    | -      |   |   |   | - |   |   |   | (551,430 | ) |   |   | (551,430 | ) |
|                                                                                                                                                    |   |             |   |   |         |   |   |       |   |   |        |   |   |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance, March 31, 2011                                                                                                                                 |   |             | -      |   |         | $      | -      |       |   |   | 16,325,623  |   |   | $       | 1,631  |   |   | $ | 2,052,436 |   |   | $ | (863,124 | ) |   | $ | 1,190,943 |   |

----

| Cash flows used in operating activities:                                             |   |   |     |
|--------------------------------------------------------------------------------------|--------|--------|----------|
|                                                                                 |   |   |     |
| Net loss                                                                             |   | $      | (551,430 | ) |
|                                                                                 |   |   |     |   |
| Adjustments to reconcile net loss to net cash used in operating activities:          |   |   |     |   |
|                                                                                 |   |   |     |   |
| Depreciation and amortization                                                        |   |   | 1,118    |   |
| Shares issued for services                                                           |   |   | 35,600   |   |
| Warrants issued for services                                                         |   |   | 130,751  |   |
|                                                                                 |   |   |     |   |
| Changes in operating assets and liabilities:                                         |   |   |     |   |
|                                                                                 |   |   |     |   |
| Increase in accounts receivable                                                      |   |   | (97      | ) |
| Increase in prepaid expenses and other current assets                                |   |   | 7,558    |   |
| Decrease in accounts payable and accrued expenses                                    |   |   | 152,292  |   |
|                                                                                 |   |   |     |   |
| Net cash used in operating activities                                                |   |   | (224,208 | ) |
|                                                                                 |   |   |     |   |
| Cash flows provided by investing activities - Cash acquired in iSafe acquisition     |   |   | 238,418  |   |
|                                                                                 |   |   |     |   |
| Cash flows provided by (used in) financing activities:                               |   |   |     |   |
|                                                                                 |   |   |     |   |
| Proceeds from sale of common stock                                                   |   |   | 72,503   |   |
| Proceeds from the exercise of warrants                                               |   |   | 92,799   |   |
| Repayment of notes payable                                                           |   |   | (4,619   | ) |
|                                                                                 |   |   |     |   |
| Net cash flows provided by financing activities                                      |   |   | 160,683  |   |
|                                                                                 |   |   |     |   |
| Net increase in cash                                                                 |   |   | 174,893  |   |
|                                                                                 |   |   |     |   |
| Cash - Beginning of period                                                           |   |   | 19,997   |   |
|                                                                                 |   |   |     |   |
| Cash - End of period                                                                 |   | $      | 194,890  |   |
|                                                                                 |   |   |     |   |
| Supplemental disclosures of cash flow information:                                   |   |   |     |   |
|                                                                                 |   |   |     |   |
| Cash paid for:                                                                       |   |   |     |   |
| Interest                                                                             |   | $      | -        |   |
| Income taxes                                                                         |   | $      | -        |   |
|                                                                                 |   |   |     |   |
| Supplemental disclosures of non-cash operating, investing, and financing activities: |   |   |     |   |
|                                                                                 |   |   |     |   |
| Acquisition of iSafe companies:                                                      |   |   |     |   |
| Assumption of assets other than cash                                                 |   | $      | 193,233  |   |
| Assumption of liabilities                                                            |   | $      | 222,474  |   |
| Issuance of common stock                                                             |   | $      | 875,000  |   |
| Issuance of warrants                                                                 |   | $      | 95,400   |   |
|                                                                                 |   |   |     |   |
| Issuance of common stock in payment of principal and interest                        |   | $      | 521,894  |   |

----

| 1)  | Business |
|----------|----------|

| 2)  | Basis of Presentation and Going Concern |
|----------|-----------------------------------------|

----

| 3)  | Significant Accounting Policies |
|----------|---------------------------------|

| Warrants                   |   |   | 5,575,000  |   |
|----------------------------|--------|--------|------------|--------|
| Preferred stock - Series A |   |   | 2,000,000  |   |
| Preferred stock - Series B |   |   | 15,000,000 |   |
| Total                      |   |   | 22,575,000 |   |

----

----

| 4)  | Intangible Assets |
|----------|-------------------|

|  a) | Rights to a royalty stream related to the sales of the Myself pelvic muscle trainer to be received during the years 2012 through 2016.  This asset will be amortized on a straight-line basis over that period or a shorter period if circumstances warrant.                   |   | $      | 2,950,000 |   |
|----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-----------|--------|
|     |                                                                                                                                                                                                                                                                                     |   |   |      |   |
|  b) | Consideration paid in excess of the net identifiable assets assumed in connection with the acquisition of the iSafe Entities as described in Note 8.  As  indicated therein, the allocation of the purchase  price is preliminary and subject to revision. |   |   | 761,223   |   |
|     |                                                                                                                                                                                                                                                                                     |   |   |      |   |
|     | Total                                                                                                                                                                                                                                                                                    |   | $      | 3,711,223 |   |

| 5)  | Notes Payable |
|----------|---------------|

| a) | On December 8, 2010 in connection with the acquisition of rights to a royalty stream related to the sales of the Myself pelvic muscle trainer, the Company issued a convertible promissory note in the principal amount of $2,000,000. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | This note accrues interest at the rate of 10% per annum and such interest is payable monthly beginning January 1, 2011.  The principal amount is due in six equal quarterly installments beginning on March 31, 2011 and ending on June 30, 2012.  Principal and accrued interest is convertible into common stock at the rate of $1.50 per share at any time at the option of the holder.  The Company has the option at any time to pay principal and accrued interest with common stock in lieu of cash at the rate of $1.00 per common share. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | On March 31, 2011, the Company elected to pay principal of $333,333 and accrued interest of $60,821 through the issuance of 394,154 shares of common stock at the rate of $1.00 per share as permitted under the terms of the note. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b) | On December 13, 2010 in connection with the acquisition of rights and intangible assets related to a novel medical applicator, the Company issued a convertible promissory note in the principal amount of $125,000. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | This note accrues interest at the rate of 10% per annum.  Principal and accrued interest is due on February 28, 2011.  Principal and accrued interest is convertible into common stock at the rate of $1.50 per share at any time at the option of the holder.  The Company has the option at any time to pay principal and accrued interest with common stock in lieu of cash at the rate of one $1.00 per common share. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | On February 28, 2011, this note matured and the Company elected to pay principal of $125,000 and accrued interest of $2,740 through the issuance of 127,740 shares of common stock at the rate of $1.00 per share as permitted under the terms of the note. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c) | On December 16, 27, and 29, 2010, the Company entered into a series of promissory notes with Rockland, the Company's majority shareholder and an entity controlled by one of the Company's Directors (the “Promissory Notes”) in the principal amounts of $10,000, $5,000, and $20,000, respectively.  Under the terms of the Promissory Notes, interest accrues at the rate of 15% per annum and, as amended to extend the terms and consolidate the individual notes, the principal and accrued interest is due on June 28, 2011. |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| d) | In connection with the acquisition of the iSafe companies as described in Note 8, the Company assumed several notes payable with an aggregate principal amount of $90,951.  These notes accrue interest at rates ranging from 6.8% to 14.2%, require monthly principal and interest payments, are partially collateralized by assets of the Company, and mature on various dates through 2016: |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2012  |   | $      | 1,069,443 |   |
|-------|--------|--------|-----------|--------|
| 2013  |   |   | 698,930   |   |
| 2014  |   |   | 13,685    |   |
| 2015  |   |   | 11,029    |   |
| 2016  |   |   | 5,041     |   |
| Total |   | $      | 1,798,129 |   |

| 6)  | Issuance of Common Stock |
|----------|--------------------------|

| a) | On various dates during January, February, and March 2011, the Company issued 44,500 shares of common stock under the terms of a service agreement as described in Note 9(a).  Such shares were valued at an average of $0.80 per share based upon the most recent amount per share for which the Company sold shares of common stock to third-party investors and the most recent closing price of the Company's shares. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| b) | On February 28, 2011 and March 31, 2011, the Company issued a total of 521,894 shares of common stock at the rate of $1.00 per share in payment of principal and interest due under the notes payable as described in Note 5(a) and 5(b). |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c) | On March 22, 2011, the Company issued 500,000 shares of common stock in connection with the acquisition of iSafe as described in Note 8.  Such shares were valued at $1.75, the most recent amount per share for which the Company sold shares of common stock to third-party investors. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 7) | Issuance of Warrants |
|----|----------------------|

| Risk free interest rate  |   |   | 2.1%   |   |
|--------------------------|--------|--------|--------|--------|
| Dividend yield           |   | Zero   |   |
| Volatility               |   |   | 100%   |   |
| Expected term (in years) |   |   | 3.0    |   |

| 8)  | Acquisition of the iSafe Companies |
|----------|------------------------------------|

----

| Assets acquired:                          |   |   |      |
|-------------------------------------------|--------|--------|-----------|
| Cash                                      |   | $      | 238,418   |   |
| Receivables                               |   |   | 109,063   |   |
| Prepaid expenses and other current assets |   |   | 2,315     |   |
| Property and equipment                    |   |   | 81,855    |   |
| Intangibles                               |   |   | 761,223   |   |
|                                      |   |   | 1,192,874 |   |
|                                      |   |   |      |   |
| Liabilities assumed:                      |   |   |      |   |
| Accounts payable and accrued expenses     |   |   | 131,523   |   |
| Notes payable                             |   |   | 90,951    |   |
|                                      |   |   | 222,474   |   |
|                                      |   |   |      |   |
| Purchase price                            |   | $      | 970,400   |   |

----

|                                                  |   | Pro Forma |       |
|-------------------------------------------------------|--------|-----------|------------|
| Revenues                                              |   | $         | 316,255    |   |
| Net loss                                              |   | $         | (481,874   | ) |
| Weighted average number of common shares outstanding  |   |      | 15,759,158 |   |
| Loss per common share – Basic and fully diluted |   | $         | (0.03      | ) |

| 9)  | Commitments & Contingencies |
|----------|---------------------------------|

| a) | On November 4, 2010, the Company entered into a financial advisory services agreement for a period of ten months under which it is obligated to pay $10,000 per month and issue 11,125 shares of common stock per month in arrears as consideration.  The Company recorded a charge of $36,500 under this arrangement for the three months ended March 31, 2011. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b) | On March 22, 2011, the Company acquired the iSafe companies as described in Note 8.  In that connection, it assumed the remaining lease obligations for two office facilities.  The aggregate remaining payments to be made under those agreements are summarized as follows: |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Balance of 2011 |   | $      | 43,385  |   |
|-----------------|--------|--------|---------|--------|
| 2012            |   |   | 55,380  |   |
| 2013            |   |   | 35,844  |   |
| 2014            |   |   | 6,795   |   |
| Total           |   | $      | 141,404 |   |

| 10)  | Subsequent Events |
|-----------|-------------------|

| a) | On April 27, 2011, the Company issued 14,000 shares of common stock at $1.80 per share to a private investor and received proceeds of $25,200. |
|----|------------------------------------------------------------------------------------------------------------------------------------------------|

----

| b) | On May 3, 2011, the Company entered into a promissory note arrangement with Rockland, the Company's majority shareholder and an entity controlled by one of the Company's Directors in the principal amount of $55,000.  Under the terms of this note, interest accrues at the rate of 15% per annum and the principal and accrued interest is due on June 28, 2011.  While the funds have been received by the Company, this arrangement has not been formalized as of the date of this report. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ITEM 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|--------|---------------------------------------------------------------------------------------------|

| a) | The rights to a royalty stream related to the sales of the Myself® pelvic muscle trainer with royalty payments expected to be received during the years 2012 through 2016. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | The Myself® pelvic muscle trainer is the first FDA-cleared, non-prescription product available direct to the consumer for the treatment of female incontinence.  This innovative device may provide some consumers a truly “curative” private solution to female incontinence.  The product is a home-use biofeedback product with proprietary technology that allows a woman to successfully strengthen her pelvic floor muscles on her own.  In addition to urinary incontinence, the Myself® product is an effective therapeutic choice for a number of other pelvic floor weakness-related conditions affecting millions of women.  These include conditions arising out of pregnancy, menopausal symptoms, pelvic organ relaxation, and female sexual dysfunction. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b) | A patent and certain related assets for a novel medical applicator. |
|----|---------------------------------------------------------------------|

|   | This novel medical applicator is capable of delivering medicants and internal devices within the body in an atraumatic fashion (without producing injury or damage).  The medical applicator technology has a number of potential uses in the medical device field.  These include translumenal delivery of arterial repair devices such as stents and grafts, insertion of analgesics and other medicines to specific locations within a body orifice or vessel, and delivery of tamponading devices for achieving hemostasis within a body cavity.  Of these applications, the use of the applicator technology as a vaginal tampon delivery device offers the largest and nearest-term commercial potential due to its large consumer market and is the first potential product we are currently researching and testing. |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | A development team is currently working to refine the design criteria and market parameters for the project which will help them create clinical testing prototypes of the delivery device in its tampon applicator form.  The tampon applicator under development is designed to replace the plastic and cardboard applicators currently used by women to insert tampons.  Targeted advantages for the new applicator include easier and pain-free insertion, superior disposability (flushable/biodegradable), and smaller size at a cost equal to or less than current plastic applicators. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| c) | Acquired all of the outstanding securities of the iSafe Entities, which are now our wholly-owned subsidiaries. |
|----|----------------------------------------------------------------------------------------------------------------|

----

|   | The iSafe Entities provide digital file conversion services that convert legacy information of various formats into valuable, usable information.  Services include document imaging, tape copying and transcription, data replication, and disaster recovery.  Additional services provided by the iSafe Entities include physical storage and management of hard copy records and paper materials, document retention planning, and document disposal.  These services enable the iSafe Entities to create unique and comprehensive data and information management solutions that deliver maximum value to their business and user communities. |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | According to the unaudited financial statements of the iSafe Entities, the companies had combined revenue of nearly $1.3 million in 2010, an increase of more than one-third over the 2009 revenue of approximately $0.9 million.  Major iSafe Entities’ customers include companies in the oil and gas, telecommunications, engineering, and medical sectors. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | As we completed this acquisition on March 22, 2011, our operating results for the three months ended March 31, 2011 include only nine days of iSafe's operating results which were not representative of overall operations of that business. |
|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | $      | 161,000  |   | Proceeds from financing activities             |
|--------|--------|----------|--------|------------------------------------------------|
|   |   | 238,000  |   | Cash acquired in acquisition of iSafe entities |
|   |   | (224,000 | )      | Cash used in operating activities              |
|   | $      | 175,000  |   | Net increase                                   |

----

| a) | Valuation and recovery of intangible assets; and |
|----|--------------------------------------------------|

| b) | Stock-based compensation. |
|----|---------------------------|

| ITEM 3 | Quantitative and Qualitative Disclosures About Market Risk |
|--------|------------------------------------------------------------|

| ITEM 4 | Controls and Procedures |
|--------|-------------------------|

| (a)  | Evaluation of Disclosure Controls and Procedures |
|-----------|--------------------------------------------------|

----

| (b)  | Remediation of Material Weaknesses |
|-----------|------------------------------------|

| (c)  | Changes in Internal Control over Financial Reporting |
|-----------|------------------------------------------------------|

----

| ITEM 1 | Legal Proceedings |
|--------|-------------------|

| ITEM 1A | Risk Factors |
|---------|--------------|

| ITEM 2 | Unregistered Sales of Equity Securities and Use of Proceeds |
|--------|-------------------------------------------------------------|

| ITEM 3 | Defaults Upon Senior Securities |
|--------|---------------------------------|

| ITEM 4 | (Removed and Reserved) |
|--------|------------------------|

| ITEM 5 | Other Information |
|-------------|-------------------|

----

----

| ITEM 6 | Exhibits |
|--------|----------|

| (a)  | Exhibits |
|-----------|----------|

| 2.1 (1)  |   | Plan of Reorganization of AP Corporate Services, Inc.                                                                                   |
|----------|--------|-----------------------------------------------------------------------------------------------------------------------------------------|
|     |   |                                                                                                                                    |
| 3.1 (1)  |   | Articles of Incorporation of I-Web Media, Inc. filed April 29, 2010                                                                     |
|     |   |                                                                                                                                    |
| 3.2 (5)  |   | Amended Articles of Incorporation of I-Web Media, Inc., filed December 8, 2010 (effective December 29, 2010)                            |
|     |   |                                                                                                                                    |
| 3.3 (5)  |   | Restated Articles of Incorporation of Heartland Bridge Capital, Inc., filed December 8, 2010 (effective December 29, 2010)              |
|     |   |                                                                                                                                    |
| 3.4 (1)  |   | Bylaws of I-Web Media, Inc.                                                                                                             |
|     |   |                                                                                                                                    |
| 3.5 (5)  |   | Restated Bylaws of Heartland Bridge Capital, Inc.                                                                                       |
|     |   |                                                                                                                                    |
| 10.1 (1) |   | Form of “A” Warrant                                                                                                         |
|     |   |                                                                                                                                    |
| 10.2 (1) |   | Form of “B” Warrant                                                                                                         |
|     |   |                                                                                                                                    |
| 10.3 (1) |   | Form of “C” Warrant                                                                                                         |
|     |   |                                                                                                                                    |
| 10.4 (1) |   | Form of “D” Warrant                                                                                                         |
|     |   |                                                                                                                                    |
| 10.5 (1) |   | Form of “E” Warrant                                                                                                         |
|     |   |                                                                                                                                    |
| 10.6 (2) |   | Agreement to Purchase Common Stock by and between Kenneth S. Barton, Rockland Group, LLC, and I-Web Media, Inc., dated November 3, 2010 |

----

| 10.7 (2)  |   | Securities Purchase Agreement by and between I-Web Media, Inc. and Rockland Group, LLC, dated November 4, 2010 |
|-----------|--------|----------------------------------------------------------------------------------------------------------------|
|      |   |                                                                                                           |
| 10.8 (3)  |   | Asset Purchase Agreement with New Horizon, Inc. dated December 9, 2010                                         |
|      |   |                                                                                                           |
| 10.9 (6)  |   | Amendment No. 1 to Asset Purchase Agreement with New Horizon, Inc.                                             |
|      |   |                                                                                                           |
| 10.10 (3) |   | Convertible Promissory Note Held by New Horizon, Inc. dated December 9, 2010                                   |
|      |   |                                                                                                           |
| 10.11 (3) |   | Assignment of Rights Agreement with New Horizon, Inc. dated December 9, 2010                                   |
|      |   |                                                                                                           |
| 10.12 (3) |   | Asset Purchase Agreement with RWIP, LLC dated December 10, 2010                                                |
|      |   |                                                                                                           |
| 10.13 (3) |   | Convertible Promissory Note Held by RWIP, LLC dated December 10, 2010                                          |
|      |   |                                                                                                           |
| 10.14 (3) |   | Warrant Agreement with RWIP, LLC dated December 10, 2010                                                       |
|      |   |                                                                                                           |
| 10.15 (3) |   | Consulting Agreement with RWIP, LLC dated December 13, 2010                                                    |
|      |   |                                                                                                           |
| 10.16 (4) |   | Development Services Agreement with NorthStar Partners Consulting, LLC, dated December 22, 2010                |
|      |   |                                                                                                           |
| 10.17 (4) |   | Warrant Agreement with NorthStar Partners Consulting, LLC, dated December 22, 2010                             |
|      |   |                                                                                                           |
| 10.18 (5) |   | Promissory Note Held by Rockland Group, LLC, dated December 16, 2010                                           |
|      |   |                                                                                                           |
| 10.19 (5) |   | Promissory Note Held by Rockland Group, LLC, dated December 27, 2010                                           |
|      |   |                                                                                                           |
| 10.20 (5) |   | Form of Warrant Issued to Officers, Directors and Consultants on December 29, 2010                             |
|      |   |                                                                                                           |
| 10.21 (7) |   | Common Stock Purchase Warrant issued to Wexford Partners, L.P. dated March 21, 2011                            |
|      |   |                                                                                                           |
| 10.22 (7) |   | Reorganization and Stock Purchase Agreement with the iSafe Entities and iSafe Holders dated March 21, 2011     |
|      |   |                                                                                                           |
| 10.23 (7) |   | Employment Agreement with Joseph W. Tischner dated March 22, 2011                                              |

----

| 10.24 (8) |   | Promissory Note Held by Rockland Group dated December 29, 2010                                                                                |
|-----------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------|
|      |   |                                                                                                                                          |
| 31.1*     |   | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer                                                                             |
|      |   |                                                                                                                                          |
| 31.2*     |   | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer                                                                             |
|      |   |                                                                                                                                          |
| 32.1*     |   | Chief Executive Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|      |   |                                                                                                                                          |
| 32.2*     |   | Chief Financial Officer Certification Pursuant to 18 USC, Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|      |   |                                                                                                                                          |

----

| * | Filed herewith. |
|---|-----------------|

| (1) | Incorporated by reference from our Registration Statement on Form 10-12G/A filed with the Commission on August 12, 2010. |
|-----|--------------------------------------------------------------------------------------------------------------------------|

| (2) | Incorporated by reference from our Current Report on Form 8-K filed with the Commission on November 8, 2010. |
|-----|--------------------------------------------------------------------------------------------------------------|

| (3) | Incorporated by reference from our Current Report on Form 8-K filed with the Commission on December 15, 2010. |
|-----|---------------------------------------------------------------------------------------------------------------|

| (4) | Incorporated by reference from our Current Report on Form 8-K filed with the Commission on December 23, 2010. |
|-----|---------------------------------------------------------------------------------------------------------------|

| (5) | Incorporated by reference from our Current Report on Form 8-K filed with the Commission on December 30, 2010. |
|-----|---------------------------------------------------------------------------------------------------------------|

| (6) | Incorporated by reference from our Current Report on Form 8-K filed with the Commission on January 14, 2011. |
|-----|--------------------------------------------------------------------------------------------------------------|

| (7) | Incorporated by reference from our Current Report on Form 8-K filed with the Commission on March 24, 2011. |
|-----|------------------------------------------------------------------------------------------------------------|

| (8) | Incorporated by reference from our Annual Report on Form 10-K filed with the Commission on April 15, 2011. |
|-----|------------------------------------------------------------------------------------------------------------|

----

|                |   | Heartland Bridge Capital, Inc.                                                                |   |
|---------------------|--------|-----------------------------------------------------------------------------------------------|--------|
|                |   |                                                                                          |   |
| Dated: May 16, 2011 |   | /s/ James F. Groelinger                                                                       |   |
|                |   | By:           James F. Groelinger      |   |
|                |   | Its:           Chief Executive Officer |   |
|                |   |                                                                                          |   |

----